Early Outcomes of Spontaneous vs. Negative-pressure Drainage After Coronary Artery Bypass Grafting
Comparison of Early-stage Outcomes of Spontaneous Drainage Versus Negative-pressure Drainage Monitoring in Patients Undergoing Coronary Artery Bypass Grafting: a Prospective Randomized Controlled Study
1 other identifier
interventional
400
1 country
1
Brief Summary
The purpose of this prospective, randomized controlled clinical trial is to evaluate early postoperative outcomes and fluid drainage dynamics between continuous active negative-pressure chest drainage (-10 mmHg) and standard spontaneous closed underwater-seal drainage in adult patients undergoing elective isolated coronary artery bypass grafting (CABG).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2026
CompletedFirst Submitted
Initial submission to the registry
September 5, 2026
CompletedFirst Posted
Study publicly available on registry
September 11, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2027
September 22, 2026
September 1, 2026
12 months
September 5, 2026
September 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pre-discharge echocardiographic assessment
Pericardial effusion volume and left ventricular ejection fraction (LVEF) measured in percentage (%) via transthoracic echocardiography prior to hospital discharge.
7-14 days after the surgery
Cumulative drainage volume at 24 and 48 hours
Total volume of thoracic drainage fluid measured in milliliters (mL) at 24 and 48 hours postoperatively.
First 24 and 48 hours after the surgery
Incidence of postoperative complications
Rate of early complications occurring within 48 hours postoperatively, including postoperative atrial fibrillation (POAF), pneumothorax, and symptomatic pleural effusion requiring intervention. Composite rate of major complications within 30 days postoperatively, including surgical re-exploration for bleeding or cardiac tamponade, requirement for extracorporeal membrane oxygenation (ECMO) support, deep sternal wound infection or sternal revision, and 30-day all-cause mortality.
It will be evaluated during the patient follow-ups at the first 48 hours and the one-month check-ups.
Secondary Outcomes (2)
Postoperative recovery metrics
from surgery to discharge (5-30 days)
Duration of intubation
10-360 hours
Study Arms (2)
No-Negative Pressure Group
NO INTERVENTIONpatients not subjected to negative pressure and managed with routine underwater-seal drainage
Negative Pressure Group
ACTIVE COMPARATORpatients monitored under negative pressure
Interventions
Continuous low-intensity active negative-pressure suction (-10mmHg) applied to chest drains via central vacuum wall suction for the first 48 hours postoperatively following coronary artery bypass grafting (CABG).
Eligibility Criteria
You may qualify if:
- Patients scheduled for elective, isolated coronary artery bypass grafting (CABG) via median sternotomy.
- Adult patients aged from 18 to 80 years.
- Patients who provide written informed consent prior to study enrollment.
You may not qualify if:
- Patients undergoing emergency coronary artery bypass grafting (CABG) or emergency surgical re-exploration.
- Patients under 18 years or over 80 years of age.
- Patients undergoing re-do cardiac surgery.
- Pre-existing pericardial effusion or significant pleural effusion detected on baseline imaging.
- Pre-existing baseline coagulopathy or active bleeding disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Başakşehir Çam Ve Sakura Şehir Hastanesi
Istanbul, Istanbul, 34480, Turkey (Türkiye)
Study Officials
- STUDY DIRECTOR
Süleyman Yazıcı, MD, Assoc. Prof.
BAŞAKŞEHİR ÇAM VE SAKURA ŞEHİR HASTANESİ
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Cardiovascular Surgery Resident
Study Record Dates
First Submitted
September 5, 2026
First Posted
September 11, 2026
Study Start
September 1, 2026
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
September 15, 2027
Last Updated
September 22, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Patient data cannot be shared with third parties, as specified during the ethics committee application.